T细胞的分子可塑性告知了它们在4T1瘤中的可能适应性
Md Iftehimul1, Robert H Newman2, Scott H Harrison2
1Institute of Biotechnology, Bangladesh Agricultural University, Mymensingh 2202, Bangladesh.
bioRxiv : the preprint server for biology
|November 24, 2025
概括
三重阴性乳腺癌 (TNBC) 的进展涉及T细胞功能下降和免疫细胞相互作用受损. 了解瘤微环境 (TME) 中的这些变化为向免疫疗法提供了机会.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 在三阴性乳腺癌 (TNBC) 中的瘤微环境 (TME) 在进展过程中从免疫活性转变为免疫抑制.
- 虽然已知瘤细胞的可塑性,但在TNBC进展过程中体内T细胞的分子可塑性尚不清楚.
研究的目的:
- 在TNBC进展过程中调查T细胞的转录性变化.
- 为了确定T细胞功能,两极分化和与抗原呈现细胞 (APC) 的相互作用的特定阶段的变化.
主要方法:
- 植入后1,3周和6周,从BALB/c小鼠获得4T1瘤的T细胞的转录分析.
- 分析与T细胞功能,细胞因子信号传递和APC-T细胞相互作用相关的基因表达.
主要成果:
- 从第1周到第6周观察到T细胞相关基因和TCR多样性的减少.
- 细胞因子信号传递的时间变化表明两极化变化:早期的Th1/Tc1,短暂的Tfc和晚期的Tc17/Tc22反应.
- 在晚期TNBC中明显出现了受损的APC-T细胞交叉和持续的巨驱动免疫抑制.
结论:
- TNBC进展的标志是T细胞功能下降,TCR多样性减少和APC相互作用受损.
- 这些免疫变化表明瘤适应免疫逃避.
- 这些发现突出了TNBC中特定阶段免疫疗法的潜在治疗窗口.
相关概念视频
T Cell Activation and Clonal Selection
14.6K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
14.6K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Special Features of Adaptive Immunity
2.9K
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
2.9K
Cell-mediated Immune Responses
83.4K
Overview
83.4K


